Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed
- 20 December 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 161 (3), 549-556
- https://doi.org/10.1007/s10549-016-4080-9
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancerBreast Cancer Research and Treatment, 2014
- Tumour heterogeneity in the clinicNature, 2013
- Patterns of Recurrence and Outcome According to Breast Cancer Subtypes in Lymph Node–Negative Disease: Results From International Breast Cancer Study Group Trials VIII and IXJournal of Clinical Oncology, 2013
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Heterogeneity in breast cancerJCI Insight, 2011
- Metastatic Behavior of Breast Cancer SubtypesJournal of Clinical Oncology, 2010
- Survival differences among women with de novo stage IV and relapsed breast cancerAnnals Of Oncology, 2010
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Breast carcinoma survival in Europe and the United StatesCancer, 2003
- THE ROLE OF CHEMOTHERAPY FOR METASTATIC BREAST CANCERHematology/Oncology Clinics of North America, 1999